Elderberry for Immune Function

Verdict: Weak, indirect evidence for immune function

Elderberry has not been shown to "boost immunity" or prevent infection; the most it may do is modestly shorten the duration of a cold or flu once you are already sick, and even that benefit is uncertain. It is not a reliable way to strengthen immune function.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

No trial has measured a direct immune-function endpoint. Every clinical study tests a symptom surrogate instead. A 2019 meta-analysis of four small RCTs (n=180; PMID 30670267) reported a large reduction in upper-respiratory symptoms, but its funding was undisclosed, so industry conflict of interest cannot be ruled out. A 2021 systematic review of five RCTs (PMID 33827515) found elderberry may shorten cold and flu duration yet does not reduce the chance of catching a cold, and rated the overall evidence as uncertain.

A 2022 systematic review in healthy people (PMID 36364865) found only one eligible elderberry trial: cold duration was about two days shorter (4.75 vs 6.88 days), but the difference in how often people got sick was not statistically significant. The only mechanistic support, increased dendritic-cell maturation and IL-6/TNF-alpha/IFN-gamma (PMID 35409309), comes from a laboratory study and was never linked to any clinical immune outcome.

Regulators and clinicians reinforce the cautious grade. The FDA lists elderberry only as a flavoring/color agent with no authorized immune claim, and the WHO notes there are no controlled clinical data. Mayo Clinic warns elderberry could overstimulate the immune system, a real concern for people with autoimmune disease or on immune-affecting drugs. Small, surrogate-based and inconsistent data, plus no regulatory backing, place this at weak Tier C.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.46
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
77%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.43
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.456
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高階證據未達主導 (0 positive vs 1 negative),由 raw_score 決定
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review
PMID: 33827515 2021 系統性回顧
Finding: Five RCTs included (1,187 records screened). Elderberry may not reduce risk of developing the common cold; may reduce cold duration/severity and influenza duration but evidence is uncertain. Three studies measured cytokine production ex vivo, but no studies linked elderberry to clinical inflammatory outcomes. Authors explicitly state there is no evidence that elderberry overstimulates the immune system; some inflammatory-marker effects may decline with ongoing supplementation.
Government Effect size: Not pooled quantitatively; benefit on duration/severity reported as uncertain
View on PubMed
Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials
PMID: 30670267 2019 統合分析 n = 180
Finding: Meta-analysis of 4 RCTs (180 participants) reported a large mean effect size for elderberry supplementation in reducing upper respiratory symptoms; effect examined against moderators including vaccination status and underlying respiratory pathology. Outcome is a symptom surrogate, not a direct measure of immune function.
Effect size: Large mean effect size on upper-respiratory symptom reduction (reported by authors)
View on PubMed
Select Dietary Supplement Ingredients for Preserving and Protecting the Immune System in Healthy Individuals: A Systematic Review
PMID: 36364865 2022 系統性回顧
Finding: Only one elderberry RCT met eligibility: among air-travellers, elderberry was associated with a roughly 2-day shorter cold duration (4.75 vs 6.88 days) and lower symptom load, but no statistically significant difference in cold incidence versus placebo. Evidence base for a general immune-function claim in healthy people was judged thin.
Effect size: Cold duration ~2 days shorter (4.75 vs 6.88 days); incidence NS
View on PubMed
Polysaccharides from European Black Elderberry Extract Enhance Dendritic Cell Mediated T Cell Immune Responses
PMID: 35409309 2022 In vitro
Finding: Water-derived elderberry polysaccharide fractions potently induced dendritic-cell maturation and raised T-cell stimulation capacity; IL-6, TNF-alpha and IFN-gamma were highly increased, whereas the ethanol extract was inactive. Demonstrates a plausible immunomodulatory mechanism, but findings are laboratory-only and do not establish a clinical immune-function benefit.
Government Effect size: Statistically higher DC maturation and T-cell stimulation vs immature controls (in vitro)
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
ELDER FLOWERS, EXTRACT (SAMBUCUS CANADENSIS L. OR SAMBUCUS NIGRA L.) — 21 CFR 182.20 — FLAVOR ENHANCER, FLAVORING AGENT OR ADJUVANT source↗
L4b EU EFSA
Neutral
L4d TW TFDA / 衛福部
Neutral
接骨木莓(Sambucus nigra)果實得供食品使用;惟接骨木之葉、莖、樹皮、未成熟果實及種子含氰苷成分,不得供食品使用。 source↗
L4e WHO
Not addressed
Although no controlled clinical data are available, the descriptions in pharmacopoeias and traditional systems of medicine justify the use of Flos Sambuci as a diaphoretic for treatment of fever and chills, and as an expectorant for treatment of mild inflammation of the upper respiratory tract; also for symptomatic treatment of the common cold. source↗
L5a NIH Office of Dietary Supplements
Cautious
L5b Mayo Clinic
Cautious
It's possible they could overstimulate your immune system, making your medications less effective or worsening your symptoms. source↗
L5c Cleveland Clinic
Neutral
L5d Harvard Health
Cautious
L5e Specialty Society (condition-mapped)
Cautious
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-immune-function-INT-elderberry-001 繁體中文版 →